Adcytherix raises €104M Series A to back new ADC drugnews2025-10-16T09:00:55+00:00October 16th, 2025|Endpoints News|
Mark Pruzanski joins Alentis as CEO after leading Intercept and Versanisnews2025-10-15T11:00:15+00:00October 15th, 2025|Endpoints News|
Hair loss biotech Pelage collects $120M for Phase 3 trialsnews2025-10-15T11:00:14+00:00October 15th, 2025|Endpoints News|
Tubulis snags $361M for clinical-stage ADCsnews2025-10-15T09:00:17+00:00October 15th, 2025|Endpoints News|
Kardigan raises $254M to test cardio drugs from Sanofi, BMS and Ionisnews2025-10-14T13:00:48+00:00October 14th, 2025|Endpoints News|
Excellergy debuts with $70M Series A and plan to take on Xolairnews2025-10-13T12:00:50+00:00October 13th, 2025|Endpoints News|
Samsara BioCapital eyes $200M opportunity fundnews2025-10-10T10:40:27+00:00October 10th, 2025|Endpoints News|
Evommune files for IPO to fund two Phase 2 autoimmune drugsnews2025-10-09T19:26:14+00:00October 9th, 2025|Endpoints News|
Former Moderna leaders raise $325M for biotech venture firm Ascenta Capitalnews2025-10-09T15:09:14+00:00October 9th, 2025|Endpoints News|
Otsuka Precision Health buys maternal meditation platform Mindful Mamasnews2025-10-09T13:32:57+00:00October 9th, 2025|Endpoints News|
